Research Knowledge Center
In-depth research documentation for laboratory compounds. All content is for scientific research purposes only and is not intended for human or veterinary use.
Peptide Reconstitution Guide: Protocols for Research Preparation
Step-by-step guide covering reconstitution of research peptides including BPC-157, GHK-Cu, retatrutide, and tirzepatide using bacteriostatic water. Covers dilution math, storage conditions, and sterile technique.
Tirzepatide vs Semaglutide: Receptor Mechanisms and Research Differences
A mechanistic comparison of tirzepatide (dual GLP-1/GIP agonist) and semaglutide (selective GLP-1 agonist), including structural differences, receptor selectivity, and considerations for research applications.
Retatrutide vs Tirzepatide: A Comparative Research Overview
A detailed comparison of retatrutide (GLP-1/GIP/glucagon triple agonist) and tirzepatide (GLP-1/GIP dual agonist) mechanisms, receptor profiles, and research applications.
What Is GHK-Cu? Research Overview of Copper Peptide GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide with broad activity in preclinical models of tissue repair, extracellular matrix remodeling, and antioxidant signaling.
What Is BPC-157? Research Overview of Body Protection Compound 157
BPC-157 is a stable synthetic pentadecapeptide of 15 amino acids derived from the gastric protein Body Protection Compound, widely studied in preclinical models.
What Is Tirzepatide? Dual GIP/GLP-1 Receptor Agonist Research Overview
Tirzepatide is a synthetic dual agonist peptide targeting GIP and GLP-1 receptors, with a once-weekly dosing interval enabled by a fatty acid conjugation strategy.
What Is Retatrutide? A Researcher's Overview of the Triple Agonist Peptide
Retatrutide is a once-weekly injectable triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, under investigation for metabolic research applications.
All research content is for laboratory and scientific research purposes only. Not for human or veterinary use. Not for clinical application.